Emily Hext partners with CEOs and founders of PE-backed and mid-market healthtech and pharmacy companies to turn strategy into action by accelerating growth, increasing enterprise value, and positioning their companies for expansion or exit.

At Legacy DNA, she brings clarity to complexity by aligning vision with execution, sharpening positioning, and building systems that drive measurable, scalable growth.

Emily has driven 300%+ growth in pharmacy adoption, exceeded Medicare acquisition goals by 115%, and led enterprise-wide brand transformations that lifted acquisition, retention, and valuation.

Her background includes executive marketing and growth leadership roles at Chevron, Humana, Priority Health, and Elevance Health, where she managed multimillion-dollar portfolios and built consumer frameworks adopted enterprise-wide.